BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25739859)

  • 1. QTc Interval Prolongation Predicts Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Wen SN; Liu N; Li SN; Wu XY; Salim M; Kang JP; Ning M; Wu JH; Ruan YF; Yu RH; Long DY; Tang RB; Sang CH; Jiang CX; Bai R; Du X; Dong JZ; Liu XH; Ma CS
    Circ J; 2015; 79(5):1024-30. PubMed ID: 25739859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc interval predicts outcome of catheter ablation in paroxysmal atrial fibrillation patients with type 2 diabetes mellitus.
    Ma N; Wu XY; Ma CS; Liu N; Bai R; Du X; Ruan YF; Dong JZ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):646-652. PubMed ID: 27752887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy.
    Wen SN; Zhu HJ; Sun PY; Wu K; Liu N; Ruan YF; Bai R; Tang RB; Yu RH; Long DY; Sang CH; Jiang CX; Li X; Li SN; Hu R; Du X; Dong JZ; Ma CS
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2405-2413. PubMed ID: 31441155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of atrial fibrillation recurrence after catheter ablation in hypertrophic cardiomyopathy patients with atrial fibrillation].
    Wen S; Liu N; Li S; Ning M; Kang J; Wu J; Ruan Y; Jiang C; Sang C; Tang R; Long D; Yu R; Bai R; Du X; Hu R; Dong J; Liu X; Ma C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Jul; 43(7):589-94. PubMed ID: 26420318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
    Santangeli P; Di Biase L; Themistoclakis S; Raviele A; Schweikert RA; Lakkireddy D; Mohanty P; Bai R; Mohanty S; Pump A; Beheiry S; Hongo R; Sanchez JE; Gallinghouse GJ; Horton R; Dello Russo A; Casella M; Fassini G; Elayi CS; Burkhardt JD; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1089-94. PubMed ID: 24114776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right atrial diameter and outcome of catheter ablation of atrial fibrillation.
    Wen S-; Liu N; Bai R; Tang RB; Yu RH; Long DY; Sang CH; Jiang CX; Li SN; Wu JH; Ruan YF; Hu R; Du X; Liu XH; Dong JZ; Ma CS
    J Interv Card Electrophysiol; 2017 Aug; 49(2):157-164. PubMed ID: 28612230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ; Munger TM; Friedman PA; Asirvatham SJ; Brady PA; Cha YM; Rea RF; Shen WK; Powell BD; Ommen SR; Monahan KH; Haroldson JM; Packer DL
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1009-14. PubMed ID: 18479329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients.
    Arya A; Hindricks G; Sommer P; Huo Y; Bollmann A; Gaspar T; Bode K; Husser D; Kottkamp H; Piorkowski C
    Europace; 2010 Feb; 12(2):173-80. PubMed ID: 19889688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.
    Di Donna P; Olivotto I; Delcrè SD; Caponi D; Scaglione M; Nault I; Montefusco A; Girolami F; Cecchi F; Haissaguerre M; Gaita F
    Europace; 2010 Mar; 12(3):347-55. PubMed ID: 20173211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
    Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†.
    Lapenna E; Pozzoli A; De Bonis M; La Canna G; Nisi T; Nascimbene S; Vicentini L; Di Sanzo S; Del Forno B; Schiavi D; Alfieri O
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1112-1118. PubMed ID: 28329110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of left atrial muscular bundles in catheter ablation of atrial fibrillation.
    Chang SL; Tai CT; Lin YJ; Wongcharoen W; Lo LW; Lee KT; Chang SH; Tuan TC; Chen YJ; Hsieh MH; Tsao HM; Wu MH; Sheu MH; Chang CY; Chen SA
    J Am Coll Cardiol; 2007 Sep; 50(10):964-73. PubMed ID: 17765124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Cryoballoon Ablation in Hypertrophic Cardiomyopathy-related Heart Failure due to Paroxysmal Atrial Fibrillation. A Comparative Case Series.
    Maagh P; Plehn G; Christoph A; Oernek A; Meissner A
    Int J Med Sci; 2016; 13(9):664-72. PubMed ID: 27647995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Asymptomatic recurrence of atrial tachy-arrhythmia after circumferential pulmonary vein isolation in patients with atrial fibrillation].
    Hao P; Ma CS; Dong JZ; Liu XP; Long DY; Fang DP; Hu FL; Yu RH; Tang RB; Lu CS; Liu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1669-72. PubMed ID: 17825144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic disease.
    Efremidis M; Bazoukis G; Vlachos K; Prappa E; Anastasakis A; Megarisiotou A; Dragasis S; Asvestas D; Mililis P; Saplaouras A; Efremidis T; Batsouli A; Zimpounoumi N; Valkanas K; Sideris A; Letsas KP
    J Electrocardiol; 2021; 69():87-92. PubMed ID: 34619440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation.
    Fein AS; Shvilkin A; Shah D; Haffajee CI; Das S; Kumar K; Kramer DB; Zimetbaum PJ; Buxton AE; Josephson ME; Anter E
    J Am Coll Cardiol; 2013 Jul; 62(4):300-5. PubMed ID: 23623910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Providencia R; Elliott P; Patel K; McCready J; Babu G; Srinivasan N; Bronis K; Papageorgiou N; Chow A; Rowland E; Lowe M; Segal OR; Lambiase PD
    Heart; 2016 Oct; 102(19):1533-43. PubMed ID: 27234160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.